CEO Virnich Daniel bought 22,640 shares of TOI at $1.04; 7 other insiders also bought within 14 days in cluster pattern
Virnich Daniel, Chief Executive Officer of Oncology Institute, Inc., purchased 22,640 shares at $1.04 on 2025-03-26, increasing his holdings to 724,363 shares (+3.2% vs pre-transaction). This open-market buy by the CEO occurs within a cluster of 7 other insider purchases over the past 14 days. The transaction timing follows a +19.2% gain over the prior 30 days and a +260.2% gain over the prior 90 days from the stock's 52-week low of $0.13. Notably, the company remains unprofitable despite +21.3% annual revenue growth to $99.9M, with a most recent quarterly net loss of $-16.1M and current market cap of $86.4M. The synchronized buy activity across multiple insiders during a period of significant stock recovery warrants observation of whether this reflects management's view on valuation or operational turnaround outlook relative to the company's ongoing loss position.